SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001079973-09-000284
Filing Date
2009-03-16
Accepted
2009-03-16 17:28:25
Documents
6
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K appy_10k-123108.htm 10-K 503171
2 CONSULTING AGMT WITH JOHN BEALER appy_10k-ex10x30.htm EX-10.30 35066
3 CONSENT OF GHP HORWATH PC appy_10k-ex23x1.htm EX-23.1 1656
4 EXHIBIT 31.1 appy_10k-ex31x1.htm EX-31.1 9286
5 EXHIBIT 31.2 appy_10k-ex31x2.htm EX-31.2 9311
6 EXHIBIT 32 appy_10k-ex32.htm EX-32 5739
  Complete submission text file 0001079973-09-000284.txt   565723
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33675 | Film No.: 09685599
SIC: 2835 In Vitro & In Vivo Diagnostic Substances